RS60777B1 - Jedinjenje izvedeno od pirazolina i njegova primena u nedeljnom doznom režimu protiv inflamacije i bola poreklom od degenerativnog oboljenja zgloba kod sisara - Google Patents
Jedinjenje izvedeno od pirazolina i njegova primena u nedeljnom doznom režimu protiv inflamacije i bola poreklom od degenerativnog oboljenja zgloba kod sisaraInfo
- Publication number
- RS60777B1 RS60777B1 RS20200943A RSP20200943A RS60777B1 RS 60777 B1 RS60777 B1 RS 60777B1 RS 20200943 A RS20200943 A RS 20200943A RS P20200943 A RSP20200943 A RS P20200943A RS 60777 B1 RS60777 B1 RS 60777B1
- Authority
- RS
- Serbia
- Prior art keywords
- treatment
- body weight
- dose
- compound
- loading dose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14382396.1A EP3009137A1 (en) | 2014-10-16 | 2014-10-16 | Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals |
| PCT/EP2015/073635 WO2016059028A1 (en) | 2014-10-16 | 2015-10-13 | Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals |
| EP15778958.7A EP3206684B1 (en) | 2014-10-16 | 2015-10-13 | Pyrazoline-derived compound and its use in a weekly dosage regimen against inflammation and pain derived from degenerative joint disease in mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS60777B1 true RS60777B1 (sr) | 2020-10-30 |
Family
ID=51844648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20200943A RS60777B1 (sr) | 2014-10-16 | 2015-10-13 | Jedinjenje izvedeno od pirazolina i njegova primena u nedeljnom doznom režimu protiv inflamacije i bola poreklom od degenerativnog oboljenja zgloba kod sisara |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11154536B2 (enExample) |
| EP (2) | EP3009137A1 (enExample) |
| JP (1) | JP6655625B2 (enExample) |
| CN (2) | CN107257684A (enExample) |
| AR (1) | AR102295A1 (enExample) |
| CA (1) | CA2964428C (enExample) |
| CY (1) | CY1123243T1 (enExample) |
| DK (1) | DK3206684T3 (enExample) |
| ES (1) | ES2828435T3 (enExample) |
| HR (1) | HRP20201233T1 (enExample) |
| HU (1) | HUE050511T2 (enExample) |
| LT (1) | LT3206684T (enExample) |
| MX (1) | MX376725B (enExample) |
| PL (1) | PL3206684T3 (enExample) |
| PT (1) | PT3206684T (enExample) |
| RS (1) | RS60777B1 (enExample) |
| SI (1) | SI3206684T1 (enExample) |
| SM (1) | SMT202000415T1 (enExample) |
| TW (1) | TWI707678B (enExample) |
| WO (1) | WO2016059028A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109303784B (zh) * | 2018-09-30 | 2020-06-23 | 山东省文登整骨医院 | 痛风性关节炎动物模型的构建方法 |
| AU2020267953A1 (en) * | 2019-05-08 | 2021-11-18 | Novartis Ag | Anti-CD40 antibodies for use in treatment of T1DM and insulitis |
| EP4029502A1 (en) | 2021-01-15 | 2022-07-20 | Ecuphar N.V. | Pyrazoline-derived compound (enflicoxib) for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals |
| US12208085B2 (en) | 2022-05-31 | 2025-01-28 | Ecuphar Nv | Pyrazoline-derived compound for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU773615B2 (en) * | 1997-05-05 | 2004-05-27 | Pfizer Inc. | COX-2 selective carprofen for treating pain and inflammation in dogs |
| ES2137138B1 (es) * | 1998-05-29 | 2000-09-16 | Esteve Labor Dr | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
| US20050131028A1 (en) * | 2003-09-11 | 2005-06-16 | Pharmacia Corporation | Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders |
| MX2007010922A (es) * | 2005-03-10 | 2007-10-12 | Genentech Inc | Metodos y composiciones para modular la integridad vascular. |
-
2014
- 2014-10-16 EP EP14382396.1A patent/EP3009137A1/en not_active Withdrawn
-
2015
- 2015-10-13 PT PT157789587T patent/PT3206684T/pt unknown
- 2015-10-13 ES ES15778958T patent/ES2828435T3/es active Active
- 2015-10-13 SI SI201531302T patent/SI3206684T1/sl unknown
- 2015-10-13 RS RS20200943A patent/RS60777B1/sr unknown
- 2015-10-13 US US15/518,871 patent/US11154536B2/en active Active
- 2015-10-13 CN CN201580068592.3A patent/CN107257684A/zh active Pending
- 2015-10-13 SM SM20200415T patent/SMT202000415T1/it unknown
- 2015-10-13 CA CA2964428A patent/CA2964428C/en active Active
- 2015-10-13 HR HRP20201233TT patent/HRP20201233T1/hr unknown
- 2015-10-13 PL PL15778958T patent/PL3206684T3/pl unknown
- 2015-10-13 LT LTEP15778958.7T patent/LT3206684T/lt unknown
- 2015-10-13 WO PCT/EP2015/073635 patent/WO2016059028A1/en not_active Ceased
- 2015-10-13 JP JP2017539508A patent/JP6655625B2/ja active Active
- 2015-10-13 EP EP15778958.7A patent/EP3206684B1/en active Active
- 2015-10-13 DK DK15778958.7T patent/DK3206684T3/da active
- 2015-10-13 HU HUE15778958A patent/HUE050511T2/hu unknown
- 2015-10-13 CN CN202210698831.5A patent/CN115154465A/zh active Pending
- 2015-10-13 MX MX2017004899A patent/MX376725B/es active IP Right Grant
- 2015-10-16 AR ARP150103353A patent/AR102295A1/es not_active Application Discontinuation
- 2015-10-16 TW TW104134072A patent/TWI707678B/zh active
-
2020
- 2020-08-03 CY CY20201100714T patent/CY1123243T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3206684T (lt) | 2020-10-12 |
| EP3206684B1 (en) | 2020-06-17 |
| EP3009137A1 (en) | 2016-04-20 |
| SI3206684T1 (sl) | 2020-11-30 |
| DK3206684T3 (da) | 2020-08-10 |
| HRP20201233T1 (hr) | 2020-11-13 |
| PT3206684T (pt) | 2020-08-24 |
| EP3206684A1 (en) | 2017-08-23 |
| JP6655625B2 (ja) | 2020-02-26 |
| PL3206684T3 (pl) | 2021-01-11 |
| HUE050511T2 (hu) | 2020-12-28 |
| CA2964428C (en) | 2022-01-04 |
| CA2964428A1 (en) | 2016-04-21 |
| CY1123243T1 (el) | 2021-10-29 |
| AR102295A1 (es) | 2017-02-15 |
| TWI707678B (zh) | 2020-10-21 |
| TW201625239A (zh) | 2016-07-16 |
| JP2017531042A (ja) | 2017-10-19 |
| US11154536B2 (en) | 2021-10-26 |
| ES2828435T3 (es) | 2021-05-26 |
| US20170231961A1 (en) | 2017-08-17 |
| CN115154465A (zh) | 2022-10-11 |
| CN107257684A (zh) | 2017-10-17 |
| WO2016059028A1 (en) | 2016-04-21 |
| MX2017004899A (es) | 2018-02-12 |
| MX376725B (es) | 2025-03-07 |
| SMT202000415T1 (it) | 2020-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence | |
| Mitchell et al. | Reversal of parkinsonian symptoms by intrastriatal and systemic manipulations of excitatory amino acid and dopamine transmission in the bilateral 6-OHDA lesioned marmoset | |
| Kutlar et al. | A dose‐escalation phase IIa study of 2, 2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease | |
| EP3206684B1 (en) | Pyrazoline-derived compound and its use in a weekly dosage regimen against inflammation and pain derived from degenerative joint disease in mammals | |
| US9993496B1 (en) | Method of administering hyaluronan formulation for supporting joint health | |
| IL268930B2 (en) | Citrulline for the treatment of sickle cell crisis | |
| CN102631667B (zh) | 促神经再生注射剂及其制备方法 | |
| AU7271700A (en) | Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats | |
| CN108295068A (zh) | 小檗碱的医药用途 | |
| WO2015084706A1 (en) | Intra-articular formulations and methods for treatment of osteoarthritis | |
| TWI605821B (zh) | 南洋山蘇水萃物的用途 | |
| US10583153B1 (en) | Method of administering hyaluronan formulation for maintaining and supporting joint health | |
| CN116889558B (zh) | 阿戈美拉汀用于制备治疗关节炎的药物的用途 | |
| US20100203146A1 (en) | Intermittent dosing strategy for treating rheumatoid arthritis | |
| CN104906501A (zh) | 治疗银屑病的中药组分组合物 | |
| Khristianovsky et al. | Technology for the use of reduced doses of diminazene aceturate for the treatment of pet babesiosis | |
| CN112439051B (zh) | 环二肽在制备治疗精神类疾病的药物中的应用 | |
| Talanov et al. | Medicinal combination of NSAIDs and carboxytherapy | |
| CN121731361A (zh) | 溶瘤病毒及其在治疗疼痛中的用途 | |
| RU2006114078A (ru) | Лекарственный препарат и способ лечения ревматических заболеваний | |
| US20130109712A1 (en) | Statins for the Prevention or Treatment of Drug Addictions | |
| KR20240014075A (ko) | 척수성 근육 위축을 치료, 예방 또는 개선시키기 위한 제약 조성물 및 그의 투여 방법 | |
| AU7419398A (en) | Use of a pharmaceutical composition in the treatment of traumatic arthritis in horses | |
| AU2020263152A1 (en) | Compositions and methods for potentiating derivatives of 4-Aminophenols | |
| Jassim et al. | A comparative study among using of Ketamine, Tramadol, and Paracetamol in three injectable anesthetic protocols for induction of general anesthesia in sheep |